Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
Muscular Dystrophy, Oculopharyngeal
Interventions
PROCEDURE

Autologous myoblasts transplantation and myotomy

Graft of autologous cell muscles (myoblasts) isolated from unaffected limb muscles into the pharyngeal muscles of patients diagnosed as suffering from OPMD and surgical procedure (myotomy)

Trial Locations (1)

75020

Hospital Tenon, Paris

All Listed Sponsors
collaborator

Association Française contre les Myopathies (AFM), Paris

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00773227 - Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts | Biotech Hunter | Biotech Hunter